Skip to content

Yuko Sekino

2 papers in the library · publishing 2015-2019

Papers

Sort Most recent Most cited

Assessment of NMDA receptor inhibition of phencyclidine analogues using a high-throughput drebrin immunocytochemical assay.

Journal of pharmacological and toxicological methods September 1, 2019 Toshinari Mitsuoka, Kenji Hanamura, Noriko Koganezawa et al.

INTRODUCTION In recent years, new psychoactive substances (NPS) have been widely distributed for abuse purposes. Effective measures to counter the spread of NPS are to promptly legislate them through the risk assessment. Phencyclidine analogues having inhibitory effects toward NMDA receptor (NMDAR) have recently emerged in Japan. Therefore, it is important to establish a high-throughput system...

MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.

Neuropharmacology August 2015 Tomohiko Irie, Ruri Kikura-Hanajiri, Makoto Usami et al.

Herbal products containing synthetic cannabinoids-initially sold as legal alternatives to marijuana-have become major drugs of abuse. Among the synthetic cannabinoids, [1-(5-fluoropentyl)-1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone (MAM-2201) has been recently detected in herbal products and has psychoactive and intoxicating effects in humans, suggesting that MAM-2201 alters brain...

DOI: 10.1016/j.neuropharm.2015.02.025 (opens in new tab) Full text (opens in new tab) Cerebellum Mam-2201 Neurotransmitter release Purkinje cell +1